NO20065662L - Esterlinkede makrolider nyttige for behandlingen av mikrobielle infeksjoner - Google Patents

Esterlinkede makrolider nyttige for behandlingen av mikrobielle infeksjoner

Info

Publication number
NO20065662L
NO20065662L NO20065662A NO20065662A NO20065662L NO 20065662 L NO20065662 L NO 20065662L NO 20065662 A NO20065662 A NO 20065662A NO 20065662 A NO20065662 A NO 20065662A NO 20065662 L NO20065662 L NO 20065662L
Authority
NO
Norway
Prior art keywords
microbial infections
esterlinked
treatment
macrolides useful
macrolides
Prior art date
Application number
NO20065662A
Other languages
English (en)
Norwegian (no)
Inventor
Sulejman Alihodzic
Stjepan Mutak
Drazen Pavlovic
Ivana Palej
Vlado Stimac
Original Assignee
Glaxosmithkline Zagreb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Zagreb filed Critical Glaxosmithkline Zagreb
Publication of NO20065662L publication Critical patent/NO20065662L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20065662A 2004-05-06 2006-12-06 Esterlinkede makrolider nyttige for behandlingen av mikrobielle infeksjoner NO20065662L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56940204P 2004-05-06 2004-05-06
US58111804P 2004-06-18 2004-06-18
PCT/IB2005/001186 WO2005108412A1 (en) 2004-05-06 2005-05-02 Ester linked macrolides useful for the treatment of microbial infections

Publications (1)

Publication Number Publication Date
NO20065662L true NO20065662L (no) 2007-01-16

Family

ID=34967616

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065662A NO20065662L (no) 2004-05-06 2006-12-06 Esterlinkede makrolider nyttige for behandlingen av mikrobielle infeksjoner

Country Status (16)

Country Link
US (1) US20080255060A1 (enExample)
EP (1) EP1756135B1 (enExample)
JP (1) JP2007536371A (enExample)
AR (1) AR049269A1 (enExample)
AT (1) ATE439367T1 (enExample)
AU (1) AU2005240849B2 (enExample)
BR (1) BRPI0510328A (enExample)
CA (1) CA2566085A1 (enExample)
DE (1) DE602005015963D1 (enExample)
ES (1) ES2331739T3 (enExample)
IL (1) IL178876A0 (enExample)
MA (1) MA28640B1 (enExample)
MX (1) MXPA06012923A (enExample)
NO (1) NO20065662L (enExample)
RU (1) RU2006143051A (enExample)
WO (1) WO2005108412A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1638549A4 (en) 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
EP1879903A1 (en) 2005-05-10 2008-01-23 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Ether linked macrolides useful for the treatment of microbial infections
AU2007330456B2 (en) * 2006-12-05 2011-03-03 Pfizer Inc. Motilide polymorphs
US9453042B2 (en) 2007-10-25 2016-09-27 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
HRP20160222T1 (hr) 2008-10-24 2016-04-08 Cempra Pharmaceuticals, Inc. Biozaštite uporabom makrolida koji sadrže triazol
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
IN2014DN08939A (enExample) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
CA2905975A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
EP2968384A4 (en) 2013-03-15 2017-02-15 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
GB201608236D0 (en) 2016-05-11 2016-06-22 Fidelta D O O Seco macrolide compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
HRP20070094T3 (hr) * 2003-05-13 2008-05-31 Glaxo Group Limited NOVI 14- i 15-EROČLANI PRSTENASTI SPOJEVI
EP1879903A1 (en) * 2005-05-10 2008-01-23 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Ether linked macrolides useful for the treatment of microbial infections

Also Published As

Publication number Publication date
AU2005240849A1 (en) 2005-11-17
ES2331739T3 (es) 2010-01-14
IL178876A0 (en) 2007-03-08
DE602005015963D1 (de) 2009-09-24
AR049269A1 (es) 2006-07-12
RU2006143051A (ru) 2008-06-20
JP2007536371A (ja) 2007-12-13
US20080255060A1 (en) 2008-10-16
AU2005240849B2 (en) 2008-10-23
WO2005108412A1 (en) 2005-11-17
MXPA06012923A (es) 2007-07-18
CA2566085A1 (en) 2005-11-17
EP1756135A1 (en) 2007-02-28
MA28640B1 (fr) 2007-06-01
ATE439367T1 (de) 2009-08-15
EP1756135B1 (en) 2009-08-12
BRPI0510328A (pt) 2007-10-23

Similar Documents

Publication Publication Date Title
EA200400536A1 (ru) Макролиды
NO20055496L (no) Pyrazolokinazolinderivater, metoder for deres fremstilling og deres anvendelse som kinaseinhibitorer
NO20065662L (no) Esterlinkede makrolider nyttige for behandlingen av mikrobielle infeksjoner
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
NO20053742L (no) Tri (cyclo)-substituerte amidforbindelser
DE60022523D1 (de) Aminopiperidinderivate als antibakterielles arzneimittel
NO20061657L (no) Pyrolderivater med antibakteriell aktivitet
NO20092639L (no) 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav
NO20075046L (no) Gastroresistente farmasoytiske formuleringer inneholdende rifaximin
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
DE60123277D1 (de) Makrolidantibiotika
NO20040511L (no) Aminoisoxazolderivater som kinaseinhibitorer
TW200626138A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626592A (en) Heterocyclic derivatives and their use as therapeutic agents
ATE504579T1 (de) Antivirale mittel
WO2006086447A3 (en) Pyridazine derivatives and their use as therapeutic agents
TW200626139A (en) Heterocyclic derivatives and their use as therapeutic agents
NO20074441L (no) 1-benzylindol-2-karboksamidderivater
NO20090443L (no) 2-metylmorfolin pyrido-, pyrazo- and pyrimido-pyrimidin derivater
WO2007044085A3 (en) Heteroaryl compounds and their uses as therapeutic agents
NO20030596D0 (no) Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse
NO20085271L (no) Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni
NO20050662L (no) COX-2 inhiberende pyridinderivater
CY1109087T1 (el) Ενωση ιμιδαζο[4,5-c]πυριδινης και μεθοδος αντι-ιικης θεραπειας
WO2004039822A3 (en) 4’’ - modified erythromycin derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application